Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BBV.BR
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics n.A.
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 0.00 0.00 0.00
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 61.60 -3.71 -9.67
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value inf 0.00 7.93
Cash inf 0.00 25.61
Capex inf 0.00 -0.07
Free Cash Flow inf 0.00 0.55
Revenue inf 0.00 1.33
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 9.58 0.38 0.35
ROA 6.77 < 0.005 < 0.005
ROE 7.25 0.04 0.04
ROIC -2.68 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BBV.BR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BBV.BR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BBV.BR is permitted for members.